Development and Validation of a HPLC and an UV Spectrophotometric Methods for Determination of Dexibuprofen in Pharmaceutical Preparations

Abstract EN

A high-performance liquid chromatographic (HPLC) and a ultraviolet (UV) methods were developed and validated for the quantitative determination of Dexibuprofen (DI) in pharmaceutical dosage form.

HPLC was carried out by reversed phase technique on a RP-18 column with a mobile phase composed of acetonitrile and 0.5% triethylamine (pH 7.5 adjusted with orthophosphoric acid (30 : 70, v/v)).

UV method was performed with the λ max at 222.0 nm.

Both the methods showed good linearity, reproducibility and precision.

No spectral or chromatographic interferences from the tablet excipients were found in UV and HPLC.

The method was successfully applied to commercial DEXIFEN tablets.

Validation parameters such as linearity, precision, accuracy, and specificity were determined.

The proposed method could be applicable for routine analysis of DI and monitoring of the quality of marketed drugs.